Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy

BACKGROUND. The objective of this study was to characterize the clinicopathologic features of sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. SUBJECTS, MATERIALS, AND METHODS. Consecutive patients with new or worsening xerostomia in the setting of ICI treatment for benign o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Warner, Blake M., Baer, Alan N., Lipson, Evan J., Allen, Clint, Hinrichs, Christian, Rajan, Arun, Pelayo, Eileen, Beach, Margaret, Gulley, James L., Madan, Ravi A., Feliciano, Josephine, Grisius, Margaret, Long, Lauren, Powers, Astin, Kleiner, David E., Cappelli, Laura, Alevizos, Ilias
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Immuno‐Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738284/
https://ncbi.nlm.nih.gov/pubmed/30996010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0823
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados